These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27357938)

  • 1. The case for the WHO Advisory Note, Global Nicotine Reduction Strategy.
    Hatsukami DK; Zaatari G; Donny E
    Tob Control; 2017 Mar; 26(e1):e29-e30. PubMed ID: 27357938
    [No Abstract]   [Full Text] [Related]  

  • 2. Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy.
    Kozlowski LT
    Tob Control; 2017 Mar; 26(e1):e31-e34. PubMed ID: 27357937
    [No Abstract]   [Full Text] [Related]  

  • 3. Paying more attention to the 'elephant in the room'.
    Borland R
    Tob Control; 2017 Mar; 26(e1):e35-e36. PubMed ID: 27357935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian urban Indigenous smokers' perspectives on nicotine products and tobacco harm reduction.
    Yuke K; Ford P; Foley W; Mutch A; Fitzgerald L; Gartner C
    Drug Alcohol Rev; 2018 Jan; 37(1):87-96. PubMed ID: 28493405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco harm reduction: the need for new products that can compete with cigarettes.
    Fagerström KO; Bridgman K
    Addict Behav; 2014 Mar; 39(3):507-11. PubMed ID: 24290207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the place of nicotine vaporisers in tobacco control.
    Gartner C; Hall W
    Tob Control; 2016 Apr; 25(e1):e1-2. PubMed ID: 27033365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential impact of vaporized nicotine products on vulnerable subpopulations.
    Gartner C
    Addiction; 2017 Jan; 112(1):18-19. PubMed ID: 27154404
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
    D'Ruiz CD; Graff DW; Yan XS
    BMC Public Health; 2015 Sep; 15():991. PubMed ID: 26424091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.
    Murphy J; Gaca M; Lowe F; Minet E; Breheny D; Prasad K; Camacho O; Fearon IM; Liu C; Wright C; McAdam K; Proctor C
    Regul Toxicol Pharmacol; 2017 Nov; 90():342-357. PubMed ID: 28954704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA's new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer.
    Proctor RN
    Tob Control; 2016 Sep; 26(5):487-488. PubMed ID: 28831030
    [No Abstract]   [Full Text] [Related]  

  • 13. Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke.
    Bell S; Dean J; Gilks C; Boyd MA; Fitzgerald L; Mutch A; Baker P; Neilsen G; Gartner CE
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28718828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine addiction, reduction, and smoking cessation.
    The Lancet
    Lancet; 2017 Aug; 390(10096):716. PubMed ID: 28831980
    [No Abstract]   [Full Text] [Related]  

  • 17. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Smoking, vaping and cardiovascular risk : an update].
    Dalkou S; Clair C
    Rev Med Suisse; 2017 Jun; 13(566):1186-1190. PubMed ID: 28640563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cigarette use in public places: striking the right balance.
    Bauld L; McNeill A; Hajek P; Britton J; Dockrell M
    Tob Control; 2017 Mar; 26(e1):e5-e6. PubMed ID: 27821792
    [No Abstract]   [Full Text] [Related]  

  • 20. Electronic Nicotine Delivery Systems, From Both Sides of the Atlantic.
    Braillon A
    Pediatrics; 2016 Mar; 137(3):e20154356. PubMed ID: 26908682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.